My Cart

Retatrutide – 20 mg (Triple-Agonist Metabolic Peptide)

Loading...

Retatrutide – 20 mg (Triple-Agonist Metabolic Peptide)

$220 USD

Disponible para reserva

Avg Duration: 7 weeks
Titration Needed: Yes
Cycle Length: Ongoing, once-weekly treatment

Retatrutide is a next-generation triple-agonist peptide targeting the GLP-1, GIP, and glucagon receptors—a powerful combination designed to dramatically improve appetite control, metabolic rate, and fat oxidation. Studies show significantly greater weight-loss potential compared to traditional single-pathway GLP-1 therapies.

Perfect for individuals seeking stronger metabolic acceleration, improved energy regulation, and enhanced appetite control through an advanced, multi-pathway mechanism.


💧 What’s included?

  • 1 vial containing 20 mg of lyophilized Retatrutide

  • 1 vial with 3 ml of sterile water for reconstitution


🔑 Key Benefits

✅ Triple-pathway activation (GLP-1 + GIP + glucagon)
✅ Strong appetite suppression and craving control
✅ Supports increased metabolic rate and fat oxidation
✅ Helps stabilize insulin response


How Long Does One Vial Last?

Duration depends on dosing:

  • Those following traditional dosing schedule – 7 weeks


Ideal For

  • Users seeking more aggressive metabolic results

  • People who haven’t responded strongly to GLP-1 alone

  • Individuals with high appetite levels or insulin resistance

  • Advanced weight-loss protocols

  • Clinics offering next-generation peptide therapy